Langguth, P. Et Al. 1997. Inhibition of P-Glycoprotein-Dependent transport Processes by Verapamil: Influence on the Pharmacokinetics of Talinolol in the Rat. . The Impact of Pharmacokinetics in Modern Drug Development (Symposium) , (California, United States Of America), 1.

Langguth, P., Ader, P., Baktır, G., Okyar, A., Radschuweit, A., Terhaag, B., ... Spahn-Langguth, H.(1997). Inhibition of P-Glycoprotein-Dependent transport Processes by Verapamil: Influence on the Pharmacokinetics of Talinolol in the Rat. . The Impact of Pharmacokinetics in Modern Drug Development (Symposium) (pp.1). California, United States Of America

Langguth, Peter Et Al. "Inhibition of P-Glycoprotein-Dependent transport Processes by Verapamil: Influence on the Pharmacokinetics of Talinolol in the Rat. ," The Impact of Pharmacokinetics in Modern Drug Development (Symposium), California, United States Of America, 1997

Langguth, Peter Et Al. "Inhibition of P-Glycoprotein-Dependent transport Processes by Verapamil: Influence on the Pharmacokinetics of Talinolol in the Rat. ." The Impact of Pharmacokinetics in Modern Drug Development (Symposium) , California, United States Of America, pp.1, 1997

Langguth, P. Et Al. (1997) . "Inhibition of P-Glycoprotein-Dependent transport Processes by Verapamil: Influence on the Pharmacokinetics of Talinolol in the Rat. ." The Impact of Pharmacokinetics in Modern Drug Development (Symposium) , California, United States Of America, p.1.

@conferencepaper{conferencepaper, author={Peter Langguth Et Al. }, title={Inhibition of P-Glycoprotein-Dependent transport Processes by Verapamil: Influence on the Pharmacokinetics of Talinolol in the Rat. }, congress name={The Impact of Pharmacokinetics in Modern Drug Development (Symposium)}, city={California}, country={United States Of America}, year={1997}, pages={1} }